Identification of a metabolic and canonical biomarker signature in Mexican HR+/HER2-, triple positive and triple-negative breast cancer patients

Publisher： Spandidos Publications

E-ISSN： 1791-2423|45|6|2549-2559

ISSN： 1019-6439

Source： International Journal of Oncology, Vol.45, Iss.6, 2014-01, pp. : 2549-2559

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The association of metabolic syndrome with triple-negative breast cancer

By Maiti B.  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 479-483

Springer Publishing Company

Access to resources Recommend Favorite

Reproductive factors and risk of estrogen receptor positive, triple-negative, and HER2-neu overexpressing breast cancer among women 20-44 years of age

By Li Christopher  

Breast Cancer Research and Treatment, Vol. 137, Iss. 2, 2013-01 ,pp. : 579-587

Springer Publishing Company

Access to resources Recommend Favorite

Expression and prognostic value of estrogen receptor β in patients with triple-negative and triple-positive breast cancer

By            

Experimental and Therapeutic Medicine, Vol. 9, Iss. 6, 2015-01 ,pp. : 2147-2150

Spandidos Publications

Access to resources Recommend Favorite

Identification of dysregulated microRNAs in triple-negative breast cancer (Review)

By  

International Journal of Oncology, Vol. 46, Iss. 3, 2015-01 ,pp. : 927-932

Spandidos Publications

Access to resources Recommend Favorite

Efficacy of ixabepilone in ER/PR/HER2-negative (triple-negative) breast cancer

By Perez Edith  

Breast Cancer Research and Treatment, Vol. 121, Iss. 2, 2010-06 ,pp. : 261-271

Springer Publishing Company

Access to resources Recommend Favorite